Celltrion news · coda.news

About

Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year.

Source: Wikipedia (CC BY-SA)

On coda.news

1 event, reported by media in 1 country

Latest news

economy7 h ago

Celltrion will look for partners in new drug development, contract manufacturing and supply chains at CPHI Worldwide in Milan (Oct 6-8).

According to The Korea Times Business, Celltrion will seek partners in new drug development, contract manufacturing, and supply chains at CPHI Worldwide in Milan from Oct. 6-8, with a focus on oncology, obesity and metabolic diseases, and autoimmune diseases. The event is in its 37th year, and over 60,000 industry professionals from about 2,400 companies in around 170 countries are expected; Celltrion will showcase its antibody drug development and manufacturing capabilities at a 152-square-meter booth.

Similar companies

Celltrion will look for partners in new drug development, contract manufacturing and supply chains at CPHI Worldwide in Milan (Oct 6-8).

economy7 h ago

coda.news AI summary

Celltrion will participate in CPHI Worldwide in Milan from Oct. 6-8.
Event is in its 37th year and expected to attract over 60,000 professionals from about 2,400 companies in 170 countries.
Celltrion aims to partner in oncology, obesity/metabolic diseases, and autoimmune diseases.
The company plans to emphasize antibody drug development and manufacturing capacity, plus CDMO partnerships.
Booth area at the event is about 152 square meters.

Celltrion

The Korea Times BusinessRead original ↗

Hyundai Engineering & Construction